Antihyperglycemic medication

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC, Eli Lilly and Company

Conditions

Type 2 DiabetesType 2 Diabetes Mellitus

Phase 4

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

Active, not recruitingNCT05433584

Eli Lilly and CompanyType 2 Diabetes

Start: 2022-08-01End: 2027-11-30Target: 780Updated: 2025-12-12

Unknown Phase

An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)

CompletedNCT01357135

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2009-07-15End: 2013-08-31Updated: 2017-06-05

Related Papers

Tirzepatide Versus Intensified Conventional Care After 2 Years of Treatment in Early Type 2 Diabetes : A Randomized Clinical Trial.

2026-05-26